Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Nursing | Psychiatry | Journal

Back to Journal Articles

Insomnia Linked to Costly Workplace Accidents, Errors

Last Updated: October 03, 2012.

 

An estimated 274,000 costly insomnia-related accidents cost the U.S. $31.1 billion annually

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Insomnia-related workplace accidents and errors are more costly and more frequent than accidents and errors caused by other chronic conditions, according to a study published online Oct. 1 in the Archives of General Psychiatry.

WEDNESDAY, Oct. 3 (HealthDay News) -- Insomnia-related workplace accidents and errors are more costly and more frequent than accidents and errors caused by other chronic conditions, according to a study published online Oct. 1 in the Archives of General Psychiatry.

Victoria Shahly, Ph.D., from Harvard Medical School in Boston, and colleagues conducted a national cross-sectional telephone survey of 4,991 commercially insured health plan members selected from the HealthCore Integrated Research Database. The validated Brief Insomnia Questionnaire was used to assess current insomnia. Other chronic conditions were assessed with claims data and self-report scales.

The researchers found that, after controlling for other chronic conditions, insomnia had a significant odds ratio with workplace accidents and/or errors (1.4). There was no significant variation in the odds ratio based on age, sex, educational level, or comorbidity. The average costs of insomnia-related accidents and errors were significantly more than those of other accidents and errors ($32,062 versus $21,914). Insomnia was estimated to be associated with 7.2 percent of all costly workplace accidents and errors and 23.7 percent of all the costs incurred by these incidents. The annualized U.S. population projections were for 274,000 costly insomnia-related workplace accidents and errors, with a combined value of $31.1 billion.

"Effectiveness trials are needed to determine whether expanded screening, outreach, and treatment of workers with insomnia would yield a positive return on investment for employers," Shahly and colleagues conclude.

Several authors disclosed financial ties to pharmaceutical companies, including Sanofi, which funded the study, and Merck, which funded data analysis and preparation of the report.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: ACS: Vaccinia Virus Studied for Triple-Negative Breast Cancer Next: Measures of Retinal Thickness Reflect CNS Pathology in MS

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.